Fig. 6
- ID
- ZDB-FIG-220628-129
- Publication
- Xu et al., 2022 - Reversion of MRAP2 Protein Sequence Generates a Functional Novel Pharmacological Modulator for MC4R Signaling
- Other Figures
- All Figure Page
- Back to All Figure Page
Wild?type and reversed Mrap2a/b differently affect the pharmacological profiles of zMc4r. (A?C) Dose?responsive stimulation of MC4R by ??MSH?induced cAMP production with different ratios of wild-type and reversed Mrap2a/b (A,B) or MRAP2 (C). (D?F) Dose?responsive inhibition of MC4R by antagonist SHU9119 with different ratios of wild-type and reversed Mrap2a/b (D,E) or MRAP2 (F). (G?I) The basal cAMP level caused by transfected MC4R, MRAP2 and RMRAP2 in the absence of an agonist. Data were analyzed by one?way ANOVA and shown as mean ± SEM of three replicates. ns (not significant difference), * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001. 2a: Mrap2a, R2a: RMrap2a, 2b: Mrap2b, R2b: RMrap2b, M2: MRAP2, RM2: RMRAP2. |